Opthalmic Consultants of Boston

Boston, Massachusetts 02114

1 studies enrolling now · 7 studies all time

What they study most

Advanced Age-related Macular Degeneration, Age Related Macular Degeneration, Age-related Macular Degeneration (AMD), Diabetic Macular Edema, Geographic Atrophy (GA), Neovascular Age-Related Macular Degeneration, Nonproliferative Diabetic Retinopathy, Steatoblepharon, Uveitis, Posterior

Studies at this site

• A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy — Recruiting now
• A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME) — Running, not enrolling
• Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis — Running, not enrolling
• The TIME-2b Study: A Study of AKB-9778 (Razuprotafib), a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) — Completed
• Phase 2b/3 Study of XAF5 Ointment for Steatoblepharon (Undereye Bags) — Completed
• Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial — Completed
• Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration — Completed